stars 1 stars 2 stars 3

CELENYS is a biotechnology company specialized in development and sale of innovative hyaluronic acid based scaffolds for 3D cell culture. CELENYS develops 3D in vitro study models to come closer to in vivo systems by mimicing the cellular microenvironment. Applications are screening of compounds during drug development (toxicology, ADME, discovery…) on 3D cell cultures and mechanistic research.

CELENYS Questions

The CELENYS annual revenue was $5 million in 2026.

CELENYS is based in Rouen, Normandy.

The NAICS codes for CELENYS are [54, 541, 5417].

The SIC codes for CELENYS are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users